World stocks nudged higher on Monday on hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial, but the gains were limited as caution prevailed before a host of central bank meetings this week.
Sterling, which has been hurt by renewed Brexit turmoil, firmed before a key vote on British...
